Preparation, Characterisation and in vitro Assessment of siRNA-loaded Lipid-Based Nanoparticles
This paper demonstrates the combined in vitro capabilities of Seda Pharmaceutical Development Services in the manufacture and physical characterisation of lipid-based nanoparticles for nucleic acid delivery, coupled with the advanced in vitro characterisation capabilities of Medicines Discovery Catapult (MDC). Together, these organisations can support the design, prototype manufacture and screening of complex medicines ready for […]
Read more